Liaoning Cheng Da Co Ltd
SSE:600739
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Liaoning Cheng Da Co Ltd
Inventory
Liaoning Cheng Da Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Liaoning Cheng Da Co Ltd
SSE:600739
|
Inventory
¥1.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
X
|
Xinhua Winshare Publishing and Media Co Ltd
SSE:601811
|
Inventory
¥3.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
A
|
Anhui Xinhua Media Co Ltd
SSE:601801
|
Inventory
¥1.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
5%
|
|
|
S
|
Sinomach Automobile Co Ltd
SSE:600335
|
Inventory
¥5.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
|
|
Zhejiang Orient Financial Holdings Group Co Ltd
SSE:600120
|
Inventory
¥1.2B
|
CAGR 3-Years
53%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-9%
|
|
|
Wuchan Zhongda Group Co Ltd
SSE:600704
|
Inventory
¥54.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Liaoning Cheng Da Co Ltd
Glance View
Liaoning Cheng Da Co Ltd stands as a significant player in the landscape of Chinese conglomerates, weaving a diverse portfolio that strategically aligns with the economic growth patterns of the region. Founded in the bustling province of Liaoning, the company epitomizes a model of diversified investment, underpinning its operations with a well-considered spread across various sectors. Initially, it carved a niche in the trading business, leveraging the abundant natural resources and industrial outputs of its home province to build a steady stream of revenue. This foundation allowed Cheng Da to expand into pharmaceuticals, real estate, and financial investments, each segment contributing distinctively to the company’s overall robustness. Cheng Da’s pharmaceutical business has emerged as a cornerstone, thriving amidst the rising demand for healthcare products in China. This arm of the company is particularly adept in leveraging advanced research methodologies combined with traditional Chinese medicine, thus creating a distinctive edge in both domestic and international markets. Meanwhile, its real estate ventures capably ride the wave of urbanization in China, focusing on premium residential and commercial properties, enhancing the urban landscape while adding to its financial metrics. By sitting at the crossroads of critical sectoral developments and maintaining a keen eye on expansive opportunities, Liaoning Cheng Da Co Ltd astutely navigates the intricate dance of market dynamics, thus cementing its place as a formidable entity in the economic engine of China.
See Also
What is Liaoning Cheng Da Co Ltd's Inventory?
Inventory
1.7B
CNY
Based on the financial report for Sep 30, 2025, Liaoning Cheng Da Co Ltd's Inventory amounts to 1.7B CNY.
What is Liaoning Cheng Da Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
3%
Over the last year, the Inventory growth was -3%. The average annual Inventory growth rates for Liaoning Cheng Da Co Ltd have been -8% over the past three years , 4% over the past five years , and 3% over the past ten years .